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The -barrel assembly machinery (BAM) is a conserved mul-
ticomponent protein complex responsible for the biogenesis of
-barrel outer membrane proteins (OMPs) in Gram-negative
bacteria. Given its role in the production of OMPs for survival
and pathogenesis, BAM represents an attractive target for the
development of therapeutic interventions, including drugs and
vaccines against multidrug-resistant bacteria such as Neisseria
gonorrhoeae. The first structure of BamA, the central compo-
nent of BAM, was from N. gonorrhoeae, the etiological agent of
the sexually transmitted disease gonorrhea. To aid in pharma-
ceutical targeting of BAM, we expanded our studies to BamD
and BamE within BAM of this clinically relevant human patho-
gen. We found that the presence of BamD, but not BamE, is
essential for gonococcal viability. However, BamE, but not
BamD, was cell-surface– displayed under native conditions;
however, in the absence of BamE, BamD indeed becomes sur-
face-exposed. Loss of BamE altered cell envelope composition,
leading to slower growth and an increase in both antibiotic
susceptibility and formation of membrane vesicles containing
greater amounts of vaccine antigens. Both BamD and BamE are
expressed in diverse gonococcal isolates, under host-relevant
conditions, and throughout different phases of growth. The
solved structures of Neisseria BamD and BamE share overall
folds with Escherichia coli proteins but contain differences that
may be important for function. Together, these studies highlight
that, although BAM is conserved across Gram-negative bacte-
ria, structural and functional differences do exist across species,
which may be leveraged in the development of species-specific
therapeutics in the effort to combat multidrug resistance.
Gram-negative bacteria, mitochondria, and plastids, such as
chloroplasts, contain integral -barrel outer membrane pro-
teins (OMPs)4 that play a myriad of pivotal physiological and
structural functions, including nutrient acquisition, secretion,
signal transduction, outer membrane biogenesis, and motility
(1, 2). In pathogenic bacteria, OMPs additionally assist in viru-
lence by facilitating host colonization and exploiting immune
responses as well as drug extrusion (3–5). Therefore, under-
standing the mechanisms that direct targeting and folding of
OMPs is critical for development of pharmaceutical interven-
tions to combat clinically important pathogens, including
the recent emergence of multidrug-resistant Neisseria gonor-
rhoeae, the etiologic agent of gonorrhea. This sexually trans-
mitted infection remains a major public health problem glob-
ally, and 78 million cases were estimated in 2012 (6). Recent
quantitative proteomic investigations of OMPs in N. gonor-
rhoeae yielded new insights into cell envelope composition and
identified new vaccine/drug protein targets that include LptD,
TamA, TamB, and the BAM complex as well as a plethora of
uncharacterized lipoproteins (7, 8).
OMPs are first synthesized in the cytoplasm with an N-ter-
minal leader sequence that routes them across the inner mem-
brane into the periplasm by the Sec system (4, 9, 10). Periplas-
mic chaperones, such as SurA, FkpA, and/or Skp, then bind the
nascent OMPs and escort them to the outer membrane where
the -barrel assembly machinery (BAM) then folds and/or
inserts them into the outer membrane (3–5, 9, 10). BAM has
been primarily investigated in Escherichia coli and Neisseria
meningitidis (3, 4, 11, 12). In E. coli, BAM is a five-protein com-
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plex consisting of BamA, an OMP itself, and four accessory
lipoproteins, BamB, BamC, BamD, and BamE (3, 5, 11). In
contrast, no BamB ortholog is present in Neisseria genomes,
whereas RmpM has been identified as an additional accessory
protein (11). BamA is the central component of BAM, and its
removal results in loss of viability. Similarly, a bamD deletion
causes lethality in E. coli and N. meningitidis, whereas lack of
other accessory Bam lipoproteins results in various degrees of
growth phenotypes and more subtle effects on cell envelope
composition and integrity (3, 11, 13–16). In vitro, all lipopro-
teins are required for fully efficient folding of OmpT, a model
OMP substrate of BAM (17, 18). BamB–E are found within the
periplasm anchored to the periplasmic leaflet of the outer
membrane via a lipid moiety at their N terminus. Albeit still
controversial, particularly with the recently reported structures
of BAM (19 –22), the helix-grip domains of BamC have also
been shown to be surface-exposed (23).
Over the past decade, the individual structures of all the Bam
proteins have been reported from E. coli, and more recently,
several groups reported the structure of fully assembled E. coli
BAM (20 –22, 24 –39). These structures have provided molec-
ular details about how the individual Bam proteins interact with
one another and revealed that the barrel domain of BamA
undergoes a large conformational change within the membrane
not previously observed in OMPs (19 –22, 30, 38 – 40). BamB
and BamD were found to interact directly with BamA with
BamD also interacting with the barrel domain. BamE was found
to not only interact with BamD as shown previously (14) but
also with BamA, bridging an additional interaction of BamA
with BamD. These structures have contributed significantly
toward our understanding of the architecture and dynamics of
BAM; however, exactly how BAM functions in E. coli remains
unknown. In Neisseria, only the structure of full-length BamA
(N. gonorrhoeae) has been reported for BAM (30) along with
the structure of RmpM (N. meningitidis) (41).
Growing lines of evidence build an appreciation for the exist-
ence of significant differences in homologous protein function,
structure, and localization, often despite a close relatedness of
the organisms. For instance, factor H– binding protein, which is
incorporated into the BEXSERO meningococcal B vaccine, is a
surface-localized protein in N. meningitidis but not in N. gon-
orrhoeae (42). Furthermore, the protein responsible for trans-
porting lipopolysaccharide in E. coli and lipooligosaccharide in
Neisseria to the cell surface, LptD, is non-essential in N. men-
ingitidis but essential in E. coli and N. gonorrhoeae (7, 43, 44).
To gain additional insight into the role of BamD and BamE
within BAM in Neisseria and to aid in future therapeutic devel-
opment, here we have performed mutagenesis and knockout
studies to assay the effects on Neisseria growth and OMP
assembly. Our work shows that BamD, but not BamE, is essen-
tial for viability and that BamE, but not BamD, is surface-ex-
posed, similar to what has been observed for BamC in E. coli.
However, in the absence of BamE, BamD did become surface-
exposed with a concomitant increase in antibiotic susceptibility
and production of membrane vesicles with altered OMP com-
position, providing further evidence that BamE may be a new
vaccine target against N. gonorrhoeae. Furthermore, to better
guide future investigations on Neisseria BAM and to assist in
structure-based therapeutic methods, we have determined the
X-ray crystal structures of both BamD and BamE from N. gon-
orrhoeae. These studies show that Neisseria BamD and BamE
share overall folds with their E. coli orthologs, but there are
differences that may be functionally important.
Results
The sequences of bamE and bamD loci in N. gonorrhoeae
BLAST searches for the gonococcal homolog of BamE pro-
tein, BamEGC, using the genome sequence of N. gonorrhoeae
strain FA1090 and sequence comparisons with Clustal Omega
(1.2.; http://www.clustal.org/omega/5; Ref. 76) resulted in iden-
tification of locus NGO1780 with 28.7 and 92.7% sequence
identity to the E. coli and N. meningitidis MC58 counterparts,
respectively (Fig. S1). The homolog of BamD, NGO0277 (here-
after BamDGC), was previously identified in N. gonorrhoeae and
named ComL (45). The deduced amino acid sequence of the
N. gonorrhoeae FA1090 BamDGC shares 33.7% sequence iden-
tity with its E. coli counterpart and 96.3% sequence identity
with the meningococcal homolog (Fig. S1). Conservation of
BamE (locus NEIP0196) and BamD (locus NEIP0653) was ana-
lyzed by comparing DNA sequences between 42,412 Neisseria
isolates deposited to the PubMLST database (https://pubmlst.
org/neisseria/5; Ref. 77) as of April 18, 2017 and demonstrated
the presence of 179 alleles with 89 single nucleotide polymor-
phisms (SNPs) for BamE and 269 alleles with 186 SNPs for
BamD (Fig. S2).
BamDGC is an essential BAM component in N. gonorrhoeae
In E. coli and N. meningitidis, both BamA and BamD are
essential proteins, and their depletion results in OMP folding,
stability, and assembly defects (11, 46 – 48). Recently, we dem-
onstrated the essential nature of BamAGC in N. gonorrhoeae (8),
but bamDGC was designated dispensable due to the successful
generation of a transposon mutant (45). This mutant, however,
showed pleiotropic phenotypes, including smaller cell size, cra-
tered and crinkled colony morphology, and reduced transfor-
mation competence.
Based on studies in E. coli and N. meningitidis (11, 46), we
reasoned that BamDGC is also essential for N. gonorrhoeae via-
bility. To test this hypothesis, we first constructed a strain in the
N. gonorrhoeae FA1090 background that carried an additional
copy of bamDGC placed under an isopropyl -D-1-thiogalacto-
pyranoside (IPTG)–inducible promoter in a different site on
the chromosome. We next insertionally inactivated the bam-
DGC gene in its chromosomal locus using the kanamycin resis-
tance cassette. The resulting strain, bamDGC/Plac::bamDGC,
formed robust colonies in the presence of the inducer but failed
to grow when subcultured on solid medium lacking IPTG (Fig.
1A). To deplete BamD during growth in liquid medium, we
applied an experimental strategy utilized previously to diminish
levels of the N. gonorrhoeae essential proteins BamA, Obg, and
GmhA (8, 49, 50). After harvesting from solid medium supple-
mented with IPTG, bamD::kan/Plac::bamD was transferred to
broth with or without IPTG. Following 3-h incubation, both
5 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party-hosted site.
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cultures were adjusted to the same optical density (shown as
time 0 h on the graph in Fig. 1B) and cultured under permissive
and non-permissive conditions for another 6 h. Omitting IPTG
in the liquid medium prevented bacterial growth (Fig. 1B),
which was concomitant with BamDGC depletion as shown by
immunoblotting with anti-BamDGC antiserum (Fig. 1C).
Together, these studies confirmed the essential nature of BamD
in N. gonorrhoeae.
N. gonorrhoeae lacking BamEGC displays a slower growth rate
in liquid medium under standard conditions
To characterize the role of BamEGC, we cloned and purified a
construct lacking the predicted lipoprotein signal peptide and
tagged with a C-terminal His6 tag and used the purified pro-
tein to raise polyclonal rabbit antiserum. The purified protein
migrated in SDS-PAGE according to a predicted molecular
mass of 12 kDa, corresponding to the recombinant protein.
Subsequently, we created a null bamEGC mutant, bamEGC,
and a complemented strain bamEGC/Plac::bamEGC, in N. gon-
orrhoeae FA1090. The anti-BamEGC antiserum cross-reacted
with wildtype whole-cell lysates. As expected, no signal was
detected in the bamEGC knockout strain, whereas the comple-
mented strain expressed BamEGC at levels proportional to the
concentrations of IPTG added (Fig. 2A). The use of 20 M IPTG
resulted in amounts of BamEGC closely resembling the native
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Figure 1. Depletion of BamDGC is lethal for N. gonorrhoeae. A, the N. gon-
orrhoeae FA1090 bamDGC::kan/Plac::bamDGC was streaked from frozen stock
on solid medium supplemented with kanamycin and IPTG. Following incuba-
tion at standard conditions, bacteria were passaged onto solid medium with
() or without () IPTG, and the colonies were examined after 22 h. Repre-
sentative photographs are shown. B and C, non-piliated colonies of N. gonor-
rhoeae bamDGC::kan/Plac::bamDGC obtained after permissive growth in the
presence of IPTG were suspended in liquid medium to an A600 of 0.1, washed,
divided, and cultured in the presence or absence of IPTG. After 3 h (shown as
time 0 h on the graph), cultures were back-diluted in fresh medium to the
same turbidity (A600 of 0.1) and cultured under permissive (black squares) and
non-permissive (red circles) conditions for an additional 6 h. At every hour,
bacterial growth was examined by measuring A600, and samples were with-
drawn for immunoblotting analysis (C) with anti-BamDGC, anti-BamAGC, anti-
BamEGC, and anti-ObgGC antisera. Migration of a molecular mass marker (kDa)
is indicated on the left. Error bars in B represent S.D.
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Figure 2. Fitness assessment of the N. gonorrhoeae null bamEGC mutant.
A, cells of N. gonorrhoeae FA1090 wildtype, isogenic bamEGC, and
bamEGC/Plac::bamEGC were harvested from solid medium supplemented
with IPTG (as indicated) and subjected to SDS-PAGE followed by immuno-
blotting with anti-BamEGC antiserum. Migration of a molecular mass marker
(kDa) is indicated on the left. B and C, non-piliated colonies of FA1090 wild-
type, isogenic bamEGC, and bamEGC/Plac::bamEGC were suspended in liquid
medium with IPTG to an A600 of 0.1 and incubated under standard aerobic
conditions for 3 h. Then, cultures were either back-diluted in fresh medium
and cultured for an additional 6 h, and growth was monitored at the indicated
time points by measuring A600 (B), or bacteria were serially diluted and plated
for fitness assessments under standard growth conditions on solid medium
(GCB), during iron limitation (Fe), in the presence of 7.5% normal human
serum (NHS), and under anaerobic conditions (O2) (C). Experiments were
performed in three biological replicates, and means with corresponding S.D.
(error bars) are presented. cfu values were enumerated after 22 h of aerobic
and 48 h of anaerobic growth.
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protein pool in the wildtype strain and consequently was cho-
sen in further complementation experiments.
The colony size of bamEGC was similar to that in a parental
strain, but a slower proliferation rate was observed during mid-
logarithmic growth in liquid medium. At the end of the exper-
iment, however, the mutant culture reached the same density as
the wildtype, and the apparent lag in growth was fully rescued in
bamEGC/Plac::bamEGC (51) (Fig. 2B). Culture supernatants
derived from bamEGC contained increased amounts of cyto-
plasmic protein markers such as Zwf, Obg, and GmhA, suggest-
ing increased cell lysis (51). Interestingly, culturing the mutant
in chemically defined Graver-Wade medium significantly
reduced this phenotype. Slower growth in liquid medium was
also observed in the Caulobacter crescentus bamE but not in
E. coli, N. meningitidis, Pseudomonas aeruginosa, or Salmo-
nella enterica serovar Typhimurium (14, 52–54). In contrast,
no significant fitness differences, as measured by counts of
colony-forming units (cfu), were noted when the wildtype,
bamEGC, and bamEGC/Plac::bamEGC were maintained on
solid medium under standard aerobic conditions as well as con-
ditions mimicking different microecological niches in the
human host, including iron deprivation, presence of normal
human serum, and anaerobiosis (Fig. 2C).
Expression of BamEGC and BamDGC
Limited information is available regarding expression of
BAM components as most research efforts have focused on
understanding the architecture and protein interactions of this
protein complex. Therefore, to further characterize the acces-
sory lipoproteins BamDGC and BamEGC, we examined their
expression patterns in the wildtype FA1090 throughout growth
in liquid medium, during exposure to environmental stimuli
relevant to different infections sites in the human host, and in a
panel of 36 different gonococcal isolates.
Both BamDGC and BamEGC were continuously expressed
throughout all stages of N. gonorrhoeae growth (Figs. 1A and
3A). A similar expression pattern was reported for BamAGC (8).
Moreover, although levels of BamDGC remained unchanged
upon exposure of N. gonorrhoeae to aerobic and anaerobic con-
ditions, upon iron limitation and in the presence of normal
human serum, expression of BamEGC was noticeably induced
during anaerobiosis (Fig. 3B). This could suggest an additional
requirement for BamEGC during anoxia, but this potential role
seems not to be sufficiently significant as fitness of N. gonor-
rhoeae lacking bamEGC was not affected under these conditions
(Fig. 2C).
Analysis of SNPs showed high conservation of both BamEGC
and BamDGC among different N. gonorrhoeae isolates (Fig. S2).
Corroborating this observation, the anti-BamEGC and anti-
BamDGC antiserum cross-reacted with whole-cell lysates
derived from common laboratory strains (FA1090, F62, MS11,
FA19, and 1291) and temporally and geographically diversified
clinical isolates, including the 2016 World Health Organization
(WHO) reference strains (Fig. 3C). In addition, these experi-
ments demonstrated that, similarly to BamAGC (8), the acces-
sory lipoproteins BamEGC and BamDGC are ubiquitously
expressed in a highly diverse pool of gonococcal isolates, fur-
ther underscoring the potential of BAM as a target for new
therapeutic interventions.
Subcellular localization studies of BamDGC and BamEGC
Using a quantitative proteomic approach, we have previously
identified BamAGC, BamDGC, and BamEGC in both cell enve-
lopes and naturally released membrane vesicles derived from
four different N. gonorrhoeae strains (7, 55). Intriguingly, differ-
ences in homologous proteins’ subcellular localization between
even closely related organisms such as N. meningitidis and
N. gonorrhoeae have been reported (42). Furthermore, recent
findings showed that E. coli BamC is exposed on the surface and
accessible to antibodies and proteases, which challenges the
dogma for the architecture of BAM (3, 23). Therefore, we first
confirmed the outer membrane localization and surface expo-
sure of BamAGC (8). Subsequently, we sought to examine the
subcellular location of BamDGC and BamEGC. Subproteome
fractions isolated from wildtype N. gonorrhoeae FA1090 were
separated by SDS-PAGE and probed with antisera against BAM
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Figure 3. Expression studies of the accessory lipoproteins BamDGC and
BamEGC in N. gonorrhoeae. A, wildtype N. gonorrhoeae FA1090 was cultured
in liquid medium, and at the indicated time points, samples were withdrawn
and processed for SDS-PAGE and immunoblotting analysis. B, quantities of
BamDGC and BamEGC in wildtype FA1090 during in vitro conditions relevant to
different infection sites (standard growth under aerobic conditions on solid
medium (GCB), in the presence of normal human serum (NHS), during iron
deprivation (Iron), and under anaerobiosis (O2)) were assessed by probing
the whole-cell lysates with respective antibodies. C, 37 strains of N. gonor-
rhoeae, as indicated above the immunoblots, were grown concurrently on
solid medium for 20 h in 5% CO2 at 37 °C, and bacteria were collected, lysed,
and processed for immunoblotting. In all experiments, samples containing
the whole-cell lysates were matched by equivalent A600 units, resolved in a
4 –20% Tris-glycine gel, and transferred onto nitrocellulose. Immunoblot
analysis was performed using polyclonal rabbit antisera against BamDGC and
BamEGC. Migration of a molecular mass marker (kDa) is indicated on the left.
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proteins as well as a cytoplasmic protein marker, ObgGC. As
expected, BamAGC and both lipoproteins, BamEGC and Bam-
DGC, were detected in the cell envelope and membrane vesicle
fractions but not in the cytoplasm or culture supernatants,
whereas ObgGC was primarily localized to the cytoplasmic
compartment (Fig. 4A).
Furthermore, to assess the surface exposure of BamEGC and
BamDGC, dot blotting and protease treatment experiments
using whole cells were performed according to optimized pro-
tocols for N. gonorrhoeae that ensure intactness of the cells (8).
Anti-BamEGC antiserum cross-reacted with intact wildtype
and bamEGC/Plac::bamEGC cells but not with cells of the
bamEGC mutant. In contrast, BamDGC was not recognized on
wildtype cells by anti-BamDGC antiserum unless the cells were
lysed (Fig. 4B). Corroborating these findings, exposing intact
gonococci to increasing concentrations of trypsin resulted in
detection of decreased amounts of BamEGC, similar to the sur-
face-exposed BamAGC, whereas levels of BamDGC; a periplas-
mic marker, SurA; and ObgGC remained unchanged (Fig. 4C).
These studies suggested that at least part of the cellular pool of
BamEGC is localized on the outside of the cell, whereas BamDGC
faces the periplasmic side of the outer membrane. In addition,
in the absence of BamEGC, BamDGC became accessible to anti-
bodies and susceptible to protease treatment. The levels of
SurA remained unchanged in bamEGC in comparison with
wildtype cells, excluding the possibility that surface localization
of BamDGC in the bamEGC mutant is solely attributable to
altered outer membrane integrity (Fig. 4C). It has been sug-
gested that both BamC and BamE stabilize the BamA-BamD
interaction. In E. coli, upon BamE depletion, BamA becomes
dramatically susceptible to exogenously added protease,
whereas periplasmic proteins, including SurA and BamD, are
completely unaffected (56). In contrast, our studies suggest that
loss of BamEGC weakens the BamAGC-BamDGC interaction,
causing a surface exposure of BamDGC with no significant
increase in the protease sensitivity of BamAGC. Furthermore,
although the absence of BamEGC had no significant impact on
the steady-state-levels of any other BAM components in the
cell envelopes of E. coli (56) and N. gonorrhoeae (Fig. 5C), deple-
tion of BamDGC resulted in an increase in the cellular pool of
both BamAGC and BamEGC (Fig. 5C).
Lack of BamEGC affects the proteome of cell envelopes and
membrane vesicles
In E. coli, loss of BamB, but not BamC or BamE, results in
significant alterations in the barrier function of the outer mem-
brane, manifested by elevated sensitivity to several antibiotics
(56). In contrast, BamE-depleted cells of N. meningitidis,
C. crescentus, and S. enterica are deficient in both outer mem-
brane assembly and integrity (11, 52, 53). To examine the
impact of BamEGC on membrane permeability, we used several
different methods and growth media, including disc diffusion,
E-tests, and phenotypic microarrays (51) (Tables 1 and 2). In
disc diffusion assays, 14 different conditions were tested with a
total of 10 compounds, including detergents and antibiotics
(vancomycin, carbenicillin, and polymyxin B), significantly
impacting the bamEGC strain in comparison with the wildtype
(Table 1). Furthermore, E-tests demonstrated significantly
lowered minimal inhibitory concentrations (MICs) for cefu-
roxime, azithromycin, ciprofloxacin, and polymyxin B (Table
2). Previously applied phenotypic microarrays with 1,056 con-
ditions and performed in defined liquid medium showed three
and six conditions uniquely beneficial and detrimental, respec-
tively, to the bamEGC mutant in comparison with six null
mutants in novel gonorrhea vaccine candidates (51). The
three beneficial compounds were osmolytes, whereas sodium
benzoate and chromium chloride attenuated the growth of
bamEGC. The mutant was also negatively affected by nalidixic
acid, rifampicin, doxycycline, and cefsulodin, which all exert
different mechanisms to kill bacteria. Similarly, loss of BamE
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Figure 4. Assessment of subcellular localization of BamDGC and BamEGC.
A, wildtype N. gonorrhoeae FA1090 harvested during the midlogarithmic
phase was subjected to proteome extraction to separate cytoplasmic pro-
teins (C), cell envelopes (CE), naturally released membrane vesicles (MV), and
soluble proteins in culture supernatants (SS). Subproteome fractions, normal-
ized based on the total amount of protein, were resolved by SDS-PAGE and
probed with polyclonal antisera against the indicated proteins. B, N. gonor-
rhoeae strains, as shown above the graphs, were cultured in liquid medium,
harvested, and suspended to the same A600 of 2.0. Intact as well as lysed cells
were spotted onto nitrocellulose membranes and probed with polyclonal
antisera against BamEGC, BamAGC, BamDGC, and ObgGC. C, N. gonorrhoeae
FA1090 wildtype and isogenic bamEGC cultures at an A600 of 1.0 were
harvested, suspended in sterile PBS, and incubated at 37 °C for 1 h without or
with increasing concentrations of trypsin as indicated above the immuno-
blot. The reaction was stopped with the addition of PMSF, cells were washed,
and individual protein profiles were analyzed by immunoblotting with spe-
cific antisera against BamEGC, BamAGC, BamDGC, SurAGC, and ObgGC. Migra-
tion of a molecular mass marker (kDa) is indicated on the left.
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caused increased sensitivity to nalidixic acid, rifampicin, and
carbenicillin in C. crescentus (52).
The sensitivity phenotype of bamEGC suggested defects in
membrane permeability, but examination of the general cell
envelope protein profile did not show apparent alterations (Fig.
5A). We therefore analyzed naturally released membrane vesi-
cles from wildtype and bamEGC. There was an increase in the
abundance of several protein species as revealed by SDS-PAGE
and Coomassie staining (Fig. 5A) and a 3-fold higher shedding
of membrane vesicles from bamEGC in comparison with the
wildtype (Fig. 5B). Outer membrane vesiculation is a well-rec-
ognized indicator of cell envelope stress (57). To gain further
insights into the scale of OMP defects associated with loss of
BamEGC, immunoblotting with antisera specific to 10 OMPs
was performed on cell envelopes and membrane vesicles
derived from the wildtype and bamEGC. These studies dem-
onstrated elevated levels of seven OMPs within the cell enve-
lope fraction with the most significant alterations observed for
AniA, Laz, and Ng-MIP (Fig. 5C). This effect was exacerbated in
the membrane vesicles where the amounts of AniA and Laz
increased over 7-fold, NGO2139 (MetQ) increased 5-fold, and
LptD increased almost 3-fold (Fig. 5D). In contrast, the other
Bam components and MtrE remained unaltered, whereas
TamA was about 2-fold depleted. These results suggest a spe-
cific contribution of BamEGC to cell envelope biogenesis.
The structures of N. gonorrhoeae BamD and BamE
To gain insights into the structure and function of BamDGC
and BamEGC and to facilitate the future targeting of BAM with
small molecule inhibitors, we obtained recombinant BamDGC
and BamEGC for structural studies as described under “Experi-
mental procedures.” The structure of BamDGC was solved by
molecular replacement to 2.5-Å resolution with final R/Rfree
values of 0.24/0.29 and contained one molecule per asymmetric
unit. The BamDGC structure closely resembles that from E. coli,
consisting of five tetratricopeptide repeat (TPR) domains and
having an overall root mean square deviation (r.m.s.d.) of 2.05 Å
(residues 30 –257) (35, 36, 58) (Fig. 6A). The shape of BamDGC
is slightly more bent than the E. coli ortholog, which is best
observed when aligning both structures along TPR1 only (Fig.
6B). Upon closer inspection, the individual TPR domains are
more conserved than the overall r.m.s.d. suggests with r.m.s.d.
values for TPR1 alone of BamDGC calculated to be 1.07 Å (res-
idues 30 – 66), for TPR2 0.704 Å (residues 67–104), for TPR3
0.583 Å (residues 105–159), for TPR4 0.675 Å (residues 160 –
210), and for TPR5 0.471 Å (residues 211–245) (Fig. 6C). Addi-
tionally, the conserved arginine residue of BamDGC (Arg-200),
important for forming a salt bridge interaction with a conserved
glutamate residue of BamA (Glu-373) (19, 21, 22, 31, 59), was
also found to be well-conserved and perfectly positioned to
serve the same role in Neisseria (Fig. 6D).
The BamEGC structure was solved by selenium single-wave-
length anomalous diffraction to 2.45-Å resolution with final
R/Rfree values of 0.20/0.24 and contained two molecules per
asymmetric unit with each monomer interacting with the other
through a - interaction along residues 30 –36 (Fig. 7A). Each
monomer contained the core  fold found in other
reported BamE structures with a calculated r.m.s.d. between
chain A and chain B of 0.61 Å (Fig. 7B). Our structure of Neis-
seria BamEGC reported here aligned reasonably well with the
core (residues 39 –106) of the other reported BamE structures,
particularly with BamE found in the E. coli BAM crystal struc-
ture (Protein Data Bank code 5EKQ), having an r.m.s.d. of 1.14
Å. r.m.s.d. values were lower for the E. coli structures solved by
NMR with calculated values of 2.00 (Protein Data Bank code
2KXX) and 2.92 Å (Protein Data Bank code 2KM7) (Fig. 7, C
and D). Interestingly, BamEGC contains an additional C-termi-
nal helix not observed in the other reported BamE structures.
Discussion
BAM is an essential multicomponent complex that resides in
the outer membranes of Gram-negative bacteria, making it an
attractive target for engineering a novel class of antibiotics that
p=0.02
M
Vs
 F
or
m
at
io
n
(m
g/
L/
O
D
60
0)
A.
0.6
150
100
75
10
kDA
CE MV
50
37
25
20
15
250
w
t
0.4
0.2
wt ∆bamE
∆b
am
E
w
t
∆b
am
E
B.
C.
LptD
TamA
BamA
BamD
BamE
AniA
Laz
MtrE
Ng-MIP
NGO2139
NGO2054
CE
w
t
∆b
am
E
LptD
TamA
BamA
BamD
BamE
AniA
Laz
MtrE
Ng-MIP
NGO2139
NGO2054
MVs
w
t
∆b
am
E
Relative to wt
Mean SD
Relative to wt 
Mean SD
1.00 ± 0.04 1.07 ± 0.14
0.96 ± 0.06 1.02 ± 0.35
1.61 ± 0.39 2.80 ± 2.83
1.46 ± 0.08 0.39 ± 0.26
2.50 ± 1.78 7.60 ± 3.94
4.70 ± 2.83 7.73 ± 4.57
2.70 ± 1.15 3.01 ± 1.54
1.03 ± 0.06 1.45 ± 0.40
1.32 ± 0.11 1.29 ± 1.10
1.75 ± 0.55 5.00 ± 3.31
D.
0.1
0
0.3
0.5
15
75
25
75
75
50
25
25
50
15
25
*
15
75
25
75
75
50
25
25
50
15
25
Figure 5. Loss of BamEGC has significant effect on the N. gonorrhoeae cell
envelope. Wildtype N. gonorrhoeae FA1090 (wt) and bamE strains were har-
vested during midlogarithmic phase and subjected to proteome extraction
to separate cell envelopes (CE) and naturally released membrane vesicles
(MV). A, C, and D, samples containing purified cell envelopes and membrane
vesicles were normalized by total protein concentration, separated by SDS-
PAGE and either visualized by Coomassie Brilliant Blue G-250 staining (A) or
transferred onto nitrocellulose membrane and probed with the indicated
antibodies, and the tested protein’s abundance was quantified by densitom-
etry (C and D). B, quantification of membrane vesicles (MVs) was achieved by
calculating the protein content in the membrane vesicles to 1.0 liter original
culture volume/OD unit (mg liter1 OD unit1). Experiments were performed
in three biological replicates. Mean values and corresponding S.D. (error bars)
are presented. Migration of a molecular mass marker (kDa) is indicated on the
left. * denotes TamA (8).
Structure and function of BamE and BamD
J. Biol. Chem. (2018) 293(4) 1106 –1119 1111
do not have to cross cellular membranes. Recent studies show
that the composition of BAM varies by bacterial species with
E. coli having at least five components within the core complex,
N. meningitidis and N. gonorrhoeae having four BAM proteins
(lacking a BamB ortholog) and RmpM, and C. crescentus having
BamF instead of BamC (11, 41, 60).
The structures of all the components of BAM in E. coli have
been solved, including the full complex (19 –22). We have pre-
viously reported the structure of the central and essential com-
ponent of BAM, BamA, from N. gonorrhoeae, and here we
report the structures of BamDGC and BamEGC (Figs. 6 and 7).
The structure of BamDGC most closely matches that of the
E. coli ortholog; however, there are small structural differences.
The structure of Neisseria BamEGC, however, deviates more
significantly compared with the E. coli ortholog with an addi-
tional C-terminal helix not previously observed in BamE. The
possible role of this helix will be explored in future studies to
determine whether it is important for BAM function.
In addition to the structures, we studied the roles of BamDGC
and BamEGC within BAM in N. gonorrhoeae. We found that
BamDGC is essential for viability, whereas BamEGC was dispens-
able, aligning well with what has been observed previously for
N. meningitidis (11) and E. coli (14, 46, 47). Analogous to the
presence of BamC on the surface of E. coli (23), we found that
BamEGC, but not BamD, was surface-displayed in our surface
labeling and protease shaving experiments (Figs. 4, B and C, and
8A). Intriguingly, we also observed BamDGC on the surface of
gonococci but only in BamEGC-depleted cells (Figs. 4, B and C,
and 8B). This suggests that the absence of BamEGC leads to
destabilization of BAM, possibly weakening the interaction
between BamAGC and BamDGC and resulting in surface expo-
sure of BamDGC. There was, however, no significant increase in
the protease sensitivity of BamAGC. It is possible that BamCGC
and (an)other yet unrecognized protein(s) docked into the
BAM complex influence BamAGC conformation. In E. coli,
both BamE and BamC are important for stabilizing the BamA-
BamD interaction, and BamE may also modulate the conforma-
tional state of BamA (56).
The lack of BamEGC was also accompanied by an increase in
antibiotic susceptibility (Tables 1 and 2 and Ref. 51) and a sig-
nificantly greater release of membrane vesicles containing
altered levels of new vaccine antigens (Fig. 8B). Cumulatively,
our experiments confirmed that BamDGC and BamEGC local-
ized to the cell envelope and membrane vesicles; showed the
ubiquitous expression of BamAGC (8), BamDGC, and BamEGC
in a diverse pool of gonococcal isolates, further underscoring
the potential of BAM as a target for novel antibiotics and vac-
cines against Neisseria; and, importantly, revealed additional
interspecies differences existing within BAM, illuminating the
need for parallel studies in different organisms to enhance
our understanding of cell envelope biogenesis. Together, these
studies indicate that, although BAM is conserved across all
Gram-negative bacteria, structural and functional differences
do exist across bacterial species and may be utilized in the
development of species-specific antibiotics and vaccines in the
effort to combat multidrug resistance.
Experimental procedures
Bacterial strains and growth conditions
N. gonorrhoeae utilized in this study include strain FA1090
(61) and 35 temporally and geographically diverse clinical iso-
lates (8, 62). E. coli strains MC1061 (63), BL21(DE3) (New Eng-
land Biolabs), and B834(DE3) (Millipore Sigma) were used for
molecular cloning and production of recombinant proteins,
Table 1
Disc diffusion assays were performed using different chemical probes and N. gonorrhoeae FA1090 isogenic wildtype, bamEGC, and
bamEGC/Plac::bamEGC
Wildtypea bamEGC
bamEGC/
Plac::bamEGC
Compound Mean S.D. n Mean S.D. n Mean S.D. n
Tween (10%) 10.31 1.1 8 12.94* 0.98 8 10.94 1.74 8
Triton X-100 (10%) 10.00 1.51 8 14.75* 3.32 8 13.50 3.62 8
SDS (5%) 27.50 1.91 4 28.50 1.00 4 27.50 1.91 4
Bile salts (10%) 11.50 1.29 4 11.75 0.95 4 11.00 1.41 4
EDTA (0.5 M) 16.67 0.57 3 17.33 0.57 3 15.67 1.52 3
Oxytetracycline (1 mg/ml) 30.75 1.70 4 33.25 1.25 4 29.25 1.70 4
Oxytetracycline (2 mg/ml) 33.80 2.58 5 35.60 1.94 5 33.60 3.84 5
Chloramphenicol (0.5 mg/ml) 31.00 1.68 4 32.75 0.48 4 26.25 1.03 4
Chloramphenicol (1 mg/ml) 35.33 2.88 3 37.33 1.15 3 30.00 3.46 3
Polymyxin B (100,000 units) 10.17 1.83 6 13.17* 2.22 6 10.67 2.22 6
Vancomycin (30 mg/ml) 23.50 1.73 4 27.40* 2.80 5 25.40 1.67 5
Carbenicillin (1 mg/ml) 31.00 2.64 3 34.00 2.00 3 30.00 1.00 3
Carbenicillin (2.5 mg/ml) 33.00 2.64 3 35.67 2.08 3 34.00 0.00 3
Carbenicillin (5 mg/ml) 36.29 1.89 7 38.86* 0.94 7 34.86 1.12 7
a N. gonorrhoeae FA1090 wildtype, isogenic bamE, and complemented strain bamE/Plac::bamE were collected from solid medium and suspended in GCBL to an A600 of
0.2, and 100 l of cell suspensions was plated on GCB supplemented with IPTG. Subsequently, sterile paper discs immersed in 10 l of various chemicals, as indicated,
were placed on the surface of the agar. Inhibition zone was recorded (mm) after 22 h of incubation. The data are presented as mean values with corresponding S.D. values
and the number of biological replicates (n). * indicates statistically significant differences with p  0.05.
Table 2
Minimal inhibitory concentration in the absence of BamEGC measured
using E-test
Antibiotic Wildtypea bamEGC
Cefuroxime 0.016 0.016
Cefotaxime 0.004 0.004
Azithromycin 0.064 0.032
Tetracycline 0.125 0.125
Ciprofloxacin 0.004 0.002
Polymyxin B 128 64
Ampicillin 0.125 0.125
Benzylpenicillin 0.125 0.125
a The N. gonorrhoeae wildtype and bamEGC cells were suspended to McFarland
standard of 0.5, spread on solid medium, and allowed to dry. E-test strips with
different antibiotics were placed on the top of the agar, and bacteria were incu-
bated for 22 h. The following day, the MICs of tested antibiotics were deter-
mined based on the zone of bacterial growth inhibition.
Structure and function of BamE and BamD
1112 J. Biol. Chem. (2018) 293(4) 1106 –1119
respectively. N. gonorrhoeae strains were maintained on either
gonococcal base solid medium (GCB; Difco), GCB without Kel-
logg’s Supplement II and with deferoxamine mesylate salt (Des-
feral, Sigma) at 5 M final concentration (iron-limited condi-
tions), GCB with the addition of 7.5% normal human serum
(NHS), or GCB with 1.2 M nitrite as a terminal electron accep-
tor (anaerobic conditions) (8) or were cultured under standard
growth conditions in gonococcal base liquid medium (GCBL)
supplemented with sodium bicarbonate at a final concentration
of 0.042% and Kellogg’s Supplements I (1:100) and II (1:1000)
(64). Gonococci were streaked from glycerol stocks maintained
at 80 °C onto GCB and incubated for 22 h at 37 °C with 5%
atmospheric CO2. Piliated or non-piliated colonies were pas-
saged onto fresh GCB for an additional 22-h incubation. Pili-
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ated colonies were used for transformation, whereas non-pili-
ated variants were used in all other experiments. E. coli strains
were grown either on Luria-Bertani agar (LBA; Difco) or cul-
tured in Luria-Bertani broth (LB; Difco) at 37 °C. Antibiotics
were used in the following concentrations: for N. gonorrhoeae,
kanamycin, 40 g/ml; and erythromycin, 0.5 g/ml; for E. coli,
kanamycin, 50 g/ml; erythromycin, 250 g/ml; and carbeni-
cillin, 50 or 100 g/ml as specified in the text.
Genetic manipulations
Oligonucleotides used in this study (Table S1) were designed
using SnapGene software version 2.8 (GSL Biotech LLC)
based on the genomic sequence of N. gonorrhoeae FA1090
(NC_002946). Primers were synthesized by Integrated DNA
Technologies. Genomic DNA of N. gonorrhoeae FA1090 was
purified with the Wizard Genomic DNA Purification kit (Pro-
mega) or purchased directly from ATCC and used as template
in PCRs with applicable oligonucleotides and Q5 high-fidelity
DNA polymerase (New England Biolabs). PCR products and
plasmid DNA were purified using a QIAprep Spin Miniprep kit
(Qiagen). Obtained genetic constructs were verified by Sanger
sequencing at the Center for Genomic Research and Biocom-
puting at Oregon State University and USA Macrogen. Trans-
formation of N. gonorrhoeae was performed as described previ-
ously (55).
The N. gonorrhoeae FA1090 conditional bamD knockout,
bamD::kan/Plac::bamD, was constructed according to the fol-
lowing steps. First, an additional copy of the bamD gene
(NGO0277) under lac regulatory sequences, Plac::bamD (8),
was placed at an unlinked chromosomal locus between the lctP
and aspC genes using the Neisseria Insertional Complementa-
tion System, pGCC4 (65), to yield the FA1090 Plac::bamD
strain. Subsequently, a 536-bp DNA fragment containing the
N-terminal part of the bamD gene and upstream DNA region
was amplified with primers BamD-Up-F and BamD-Up-R,
digested with EcoRI/KpnI, and introduced into similarly
treated pUC18K (66), yielding pUC18K-BamD-Up. Next, the
downstream DNA fragment for allelic replacement (562 bp)
was amplified with primers BamD-Down-F/BamD-Down-R,
digested with BamHI/HindIII, and ligated into BamHI/
HindIII–cleaved pUC18K-BamD-Up. The pUC18K-bamD::kan
was linearized with HindIII and introduced into FA1090
Plac::bamD. Transformants were selected on GCB supple-
mented with kanamycin and 0.05 mM IPTG and verified for
disruption of the bamD gene with the kanamycin resistance
cassette by PCR with primers BamD-Ver-F/BamD-Ver-R and
immunoblotting analysis using BamD antiserum (8).
To generate a clean deletion of bamE in N. gonorrhoeae
FA1090, the upstream region of NGO1780 was amplified with
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Figure 8. Model of the N. gonorrhoeae BAM in the presence and absence of BamEGC. A, under wildtype BAM conditions, BamEGC, but not BamDGC, was
found localized at the cell surface of gonococci. B, in the absence of BamEGC, topological changes in BAM occur, including BamDGC becoming surface-exposed,
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primers BamE-Up-F/BamE-Up-R. The 757-bp product was
cleaved with SacI/KpnI and cloned into similarly treated
pUC18K, yielding pUC18K-BamE-Up. Subsequently, the down-
stream region from the gene encoding BamE was amplified with
primers BamE-Down-F/BamE-Down-R, and the obtained
724-bp product was cloned into BamHI/HindIII–treated
pUC18K-BamE-Up. The final product, pUC18K-bamE, was
used for an allelic exchange of bamE with the kanamycin resis-
tance cassette as described above. Deletion of bamE was con-
firmed by PCR with primers BamE-Ver-F/BamE-Ver-R using
chromosomal DNA isolated from wildtype FA1090 as controls
and by probing the whole-cell lysates of wildtype and bamE
with antiserum against BamE.
To complement the N. gonorrhoeae FA1090 bamE mutant,
first the Plac::bamE construct was generated by amplification of
bamE with native ribosome-binding site using primers cBamE-
F/cBamE-R. The 41-bp PCR product was digested with FseI
and inserted into ScaI/FseI– cleaved pGCC4, yielding pGCC4-
BamE. Next, pGCC4-BamE was introduced into the bamE
mutant by transformation, and clones were selected on GCB
containing erythromycin and validated by PCR with primers
pGCC4-Ver-F/pGCC4-Rev-R as well as immunoblotting with
anti-BamE antiserum.
To obtain pET28-rBamE used for production of recombi-
nant BamE (rBamE), which lacked the native signal peptide and
contained a C-terminal His6 tag, the ngo1780 gene was ampli-
fied with primers rBamE-F/rBamE-R and cloned into NcoI/
HindIII– digested pET28a.
The gene encoding SurA (ngo1714) lacking the DNA encod-
ing signal peptide was amplified using primers SurA-F/SurA-R.
The subsequent PCR product was digested with NcoI/HindIII
and ligated into similarly cut pRSF-NT to create a TEV
protease– cleavable C-terminal His6-tagged fusion. For struc-
tural studies, the BamD and BamE coding regions, starting after
the N-terminal cysteine, were amplified from N. gonorrhoeae
strain FA1090 genomic DNA (ATCC) and subcloned into the
pHIS-parallel2 vector using NcoI and XhoI restriction sites. All
sequences were verified by sequencing analysis (primers avail-
able upon request).
Growth assays
Depletion of BamD was achieved by applying an experimen-
tal strategy utilized previously to diminish levels of N. gonor-
rhoeae BamA, Obg, and GmhA (8, 49, 50). N. gonorrhoeae
FA1090 bamD::kan/Plac::bamD was harvested from GCB
with 0.05 mM IPTG (permissive conditions), and the A600 was
adjusted to 0.1. Bacteria were washed twice and cultured in
GCBL with or without IPTG at a final concentration of 0.05
mM. After 3 h, both cultures were diluted to an A600 of 0.1 and
cultured in fresh GCBL with or without IPTG for another 6 h.
At every hour, A600 measurements were taken, and samples
were withdrawn for immunoblotting analysis. Three biological
replicates of the experiment were performed. Mean values and
corresponding S.D. are reported.
The growth kinetics of FA1090 wildtype, bamE, and
bamE/Plac::bamE were performed in GCBL under standard
growth conditions. Bacteria were collected from GCB and
suspended in GCBL to an A600 of 0.1. Media for growing
bamE/Plac::bamE were supplemented with 0.02 mM IPTG.
Following 3 h of incubation at 37 °C with aeration (220 rpm),
bacterial cultures were back-diluted to an A600 of 0.1 in fresh
GCBL and cultured for an additional 6 h. Samples were with-
drawn for A600 measurements every hour (n  3; mean  S.D.).
To assess the viability of N. gonorrhoeae lacking bamE during
host-relevant in vitro growth conditions, colonies of FA1090
wildtype, bamE, and bamE/Plac::bamE were collected from
GCB, suspended in GCBL to an A600 of 0.1, and cultured for 3 h
at 37 °C with aeration. Subsequently, the cultures were normal-
ized to an A600 of 0.2, serially diluted, and plated on solid
medium for standard growth conditions (GCB), iron-limiting
conditions, NHS, and anaerobic conditions as described above.
All media were additionally supplemented with 0.02 mM IPTG.
The cfu values were scored after 22 and 48 h for aerobic
and anaerobic conditions, respectively. Experiments were per-
formed on three separate occasions, and mean cfu values with
corresponding S.D. are reported.
Antimicrobial susceptibility testing
Antimicrobial susceptibility was tested using a slightly mod-
ified Kirby-Bauer (disk diffusion) method (67) and E-test. In
disc diffusion experiments, FA1090 wildtype, isogenic bamE,
and bamE/Plac::bamE strains were collected from GCB, and
the suspensions were adjusted in GCBL to match an A600 of 0.2.
Cell suspensions (100 l) were immediately plated on GCB, and
6-mm filter paper disks (Whatman) impregnated with 10 l of
tested compounds, as indicated below, were placed on the sur-
face of the agar. The zones of inhibition in mm were measured
after 22 h. Experiments were performed in biological triplicates,
and mean values with S.D. are presented.
MICs for cefuroxime, cefotaxime, azithromycin, tetracy-
cline, ciprofloxacin, polymyxin B, ampicillin, and benzylpeni-
cillin were determined using an E-test (Biomerieux) according
to the manufacturer’s recommendations. Each determination
was performed on three separate occasions using fresh bacterial
cultures, and the consensus MIC obtained in at least two trials
was reported.
Protein localization assays
Subcellular fractionations, immunodotting, and trypsin
accessibility studies were performed following procedures
described previously (8). Briefly, N. gonorrhoeae FA1090 wild-
type and bamE at the midlogarithmic phase of growth were
used to extract proteins from the cytosolic, cell envelope, mem-
brane vesicle, and soluble supernatant fractions. Cell envelopes
were separated from cytoplasmic proteins by a sodium carbon-
ate extraction method and differential centrifugation, whereas
culture supernatants were subjected to filtration and ultracen-
trifugation to separate naturally released membrane vesicles
from soluble proteins. Quantification of membrane vesicles
was achieved by calculating the protein content in the mem-
brane vesicles to 1.0 liter of original culture volume/OD unit
(mg liter1 OD unit1) as described (68).
In immunodotting and protease susceptibility studies, intact
bacterial cells were used (8). For immunodotting, bacteria were
suspended in GCBL to an A600 of 0.1, cultured with aeration for
3 h, harvested, and spotted as 5-l suspensions onto a nitrocel-
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lulose membrane after adjusting the A600 to 2.0. The samples
were dried at room temperature for 15 min and subjected to
immunoblotting.
In trypsin shaving assays, gonococci were subcultured in
GCBL for 3 h after collecting from solid medium, diluted to an
A600 of 0.1, and cultured until an A600 of 1.0 was reached.
Bacteria were gently harvested and suspended in sterile PBS,
pH 8.0, to an A600 of 2.5, and 500-l suspensions were incu-
bated for 1 h at 37 °C with trypsin at final concentrations of 0,
40, or 80 g/ml. To deactivate trypsin, 10 l of 50 mM phenyl-
methylsulfonyl fluoride (PMSF) was added, bacteria were
washed with GCBL and subjected to SDS-PAGE, and trypsin
accessibility of selected proteins was detected by immunoblot-
ting with polyclonal antiserum.
Purification of rBamE and rSurA and preparation of
polyclonal antisera
An overnight culture of E. coli BL21(DE3) carrying either
pET28a-rBamE or pET28a-rSurA was back-diluted into 3.0 or
1.0 liter of LB broth, respectively, supplemented with kanamy-
cin and incubated with aeration at 37 °C. The production of
rBamE and rSurA was induced with 0.1 and 1 mM IPTG, respec-
tively, during midlogarithmic growth. Bacterial cells were col-
lected by centrifugation 3 h after induction, suspended in lysis
buffer (500 mM NaCl, 10 mM imidazole, 20 mM Tris-HCl, pH
8.0, and Complete EDTA-free protease inhibitor tablet (Roche
Applied Science)), and lysed by passaging through a French
pressure cell at 12,000 p.s.i. Unbroken cells and cell debris were
removed by centrifugation at 16,000 	 g for 30 min at 4 °C. The
cell-free lysate was passed through a 0.22-m filter unit (VWR
International) and applied onto Bio-Scale Mini Profinity immo-
bilized metal affinity chromatography cartridges (Bio-Rad).
Loosely bound proteins were removed with 10 column volumes
of wash buffer (20 mM Tris, pH 8.0, 500 mM NaCl, 40 mM imid-
azole), and proteins were eluted with a 40 –250 mM imidazole
gradient using an NGC Purification System (Bio-Rad). Frac-
tions containing rBamE were pooled and dialyzed against 20
mM Tris, pH 8.0, 10% glycerol, whereas fractions containing
eluted rSurA were incubated overnight at 4 °C with TEV
protease in a 1:20 ratio to remove the His6 tag. After concen-
trating the sample to 5 ml using Vivaspin 20 centrifuge con-
centrators (GE Healthcare), proteins were subjected to size
exclusion chromatography using a HiLoad 16/600 Superdex
75 prep grade column (GE HealthCare) with phosphate-
buffered saline (PBS) as running buffer. Finally, fractions
containing rSurA were concentrated using a Vivaspin 20
centrifuge concentrator.
Polyclonal antisera against purified rSurA and rBamE were
prepared by Pacific Immunology Corp. using a 13-week anti-
body production protocol and two New Zealand White rabbits
under Animal Protocol 1 approved by the Institutional Ani-
mal Care and Use Committee and the National Institutes of
Health Animal Welfare Assurance Program (A4182-01) in a
certified animal facility (United States Department of Agri-
culture 93-R-283). The rabbit polyclonal anti-BamD antise-
rum were obtained and evaluated previously (8).
Expression and purification of recombinant N. gonorrhoeae
BamD and BamE
For expression of BamDGC and BamEGC for structural stud-
ies, each construct was introduced into E. coli BL21(DE3)
chemically competent cells, then plated onto LBA supple-
mented with carbenicillin (100 g/ml), and incubated over-
night at 37 °C. For native expression, a single colony was used to
inoculate a 5-ml LB with carbenicillin (50 g/ml) starter cul-
ture, which was cultured to an A600 of 1.0. The cells were then
washed with fresh LB and inoculated into 2 liters of 2	 YT (16
g/liter Tryptone, 10 g/liter yeast extract, 5.0 g/liter NaCl)
medium supplemented with carbenicillin (50 g/ml). Bacteria
were cultured at 37 °C until an A600 of 0.8 was reached,
expression was induced with 0.2 mM IPTG, and bacteria were
grown an additional 8 h at 25 °C before harvesting.
For selenomethionine-substituted BamEGC, E. coli B834(DE3)
cells were transformed and plated onto LBA overnight. A single
colony was used to inoculate a 25-ml LB with carbenicillin (50
g/ml) culture and allowed to grow at 37 °C to an A600 of 0.8 –
1.0. The cells were then centrifuged, washed three times with
minimal medium lacking methionine, and resuspended in 6 ml
of wash medium, and then 1 ml was added to six flasks contain-
ing 1 liter each of minimal medium supplemented with sel-
enomethionine (40 mg/liter) and carbenicillin (50 g/ml).
These cultures were grown at 37 °C until the A600 was between
0.6 and 0.8, then induced with 0.5 mM IPTG, and allowed to
grow an additional 24 h before harvesting.
For protein purification, cells were resuspended in PBS (12
mM phosphate buffer, pH 7.4, 137 mM NaCl, 2.7 mM KCl) at 5
ml/g of cell paste and supplemented with DNase I (10 g/ml)
and PMSF (0.2 mM). The cells were then lysed by two passages
through an Avestin C3 Emulsiflex, and the lysates were centri-
fuged at 39,000 	 g for 45 min. The supernatants were then
applied to a pre-equilibrated 5-ml nickel-nitrilotriacetic acid
resin column. The column was washed with at least 5 column
volumes of PBS, a pre-elution was performed using PBS with 25
mM imidazole, and a final elution was done with PBS containing
250 mM imidazole. To remove the N-terminal His tag, TEV
protease was added to the final protein sample along with 1 mM
DTT and 0.5 mM EDTA and dialyzed overnight at 4 °C in PBS.
The dialyzed samples were then again applied to a 2-ml pre-
equilibrated nickel-nitrilotriacetic acid resin column. The fil-
trate was collected, concentrated, and then applied to a HiPrep
Sephacryl S-100 HR gel filtration column (GE Healthcare) in
PBS as a final purification step. Peak fractions were confirmed
by SDS-PAGE analysis, pooled, and concentrated to 10 mg/ml.
Crystallization and structure determination of BamD and
BamE from N. gonorrhoeae
For crystallization, the samples were screened using
commercial sparse-matrix crystallization screens on a TTP
LabTech Mosquito Crystal crystallization robot using the
hanging-drop vapor-diffusion method with a drop ratio of 1:1
(protein:well solution), and lead conditions were further opti-
mized. BamDGC was crystallized in final conditions of 1.0 M
LiCl, 100 mM HEPES, pH 7.0, 10% PEG 6000. Native and sel-
enomethionine-substituted BamEGC crystals were grown in
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final conditions of 10 mM zinc sulfate heptahydrate, 100 mM
MES monohydrate, pH 6.5, 25% PEG monomethyl ether 550.
Crystals were harvested directly from their drops, cryopro-
tected in mother liquor solution containing 20% glycerol, and
flash frozen in liquid nitrogen until data collection.
Data sets for native BamDGC and BamEGC were collected at
the GM/CA-CAT beamline 23ID at the Advanced Photon
Source, Argonne National Laboratory. Data sets for selenome-
thionine-substituted BamEGC were collected at beamline
X25 at the National Synchrotron Light Source, Brookhaven
National Laboratory. All data were processed using HKL2000
(69) or xia2 (70). The BamDGC structure was solved by molec-
ular replacement with PHASER within PHENIX (71) in space
group P43212 to 2.5-Å resolution using the E. coli BamD struc-
ture (Protein Data Bank code 2YHC) as a search model. The
BamEGC structure was solved by selenium single-wavelength
anomalous diffraction in space group P21212 to 2.45-Å resolu-
tion with AutoSol within PHENIX (71). A single selenium site
per monomer was used to calculate initial phases followed by
AutoBuild (71). All manual model building was performed with
Coot (72), and refinement was performed with phenix.refine
within PHENIX (71). Structure validation was performed using
MolProbity within PHENIX (71) using the online server (73).
r.m.s.d. analysis and rigid body fitting were performed within
PyMOL (Schrödinger). Data collection and refinement statis-
tics are summarized in Table 3. Minimization of the partial
BAM model was performed using Chiron (74). All figures were
made using PyMOL (Schrödinger) and annotated and finalized
in Adobe Photoshop/Illustrator.
SDS-PAGE and immunoblotting
Samples of whole-cell lysates, protein fractions, intact cells,
or purified proteins were normalized based on either A600 or
protein concentration as specified. Protein concentration was
measured using the DC Protein Assay (Bio-Rad). Proteins were
visualized by staining with Coomassie Brilliant Blue G-250 or
transferred onto nitrocellulose membrane using a Trans-blot
Turbo (Bio-Rad) and detected by immunoblotting as described
previously (8) using the following dilutions of primary poly-
clonal rabbit antisera: anti-BamEGC, 1:20,000; anti-BamAGC,
1:20,000 (8); anti-BamDGC, 1:10,000 (8); anti-ObgGC, 1:10,000
(49); anti-SurAGC, 1:10,000; anti-LptD, 1:5,000; anti-TamA,
1:5,000; anti-AniA, 1:10,000; anti-Laz, 1:20,000; anti-Ng-MIP,
1:10,000; anti-MtrE, 1:10,000; anti-NGO2054, 1:10,000; and
anti-NGO2139, 1: 20,000 (8).
Densitometry analysis
Protein abundance was quantified by densitometry using the
Image Lab 5.0 software (Bio-Rad) volume tool (rectangle), local
background subtraction, and linear regression method as
described previously (49, 75). Experiments were performed in
biological triplicates and are shown in Fig. S3. The relative pro-
tein levels are presented as mean values and S.D.
Statistical analysis
GraphPad Prism’s built-in t test was utilized to determine
statistically significant differences between experimental results. A
confidence level of 95% was used for all analyses.
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Table 3
Data collection and refinement statistics
r.m.s., root mean square.
BamDGC BamEGC
Data collection
Wavelength (Å) 1.0332 0.9794
Space group P43212 P21212
Cell dimensions
a, b, c (Å) 64.42, 64.42, 166.39 62.80, 86.08, 49.92
, ,  (°) 90, 90, 90 90, 90, 90
Resolution (Å) 45.55–2.50
(2.59–2.50)a
43.18–2.45
(2.54–2.45)
Rsym 0.104 (2.30) 0.160 (0.795)
Rpim 0.040 (0.813) 0.088 (0.439)
CC1⁄2b (0.500) (0.491)
I/I 17.5 (1.12) 7.2 (1.48)
Completeness (%) 99.9 (100) 98.1 (99.5)
Multiplicity 8.1 (8.8) 4.2 (4.3)
Refinement
Resolution (Å) 43.93–2.50 43.04–2.45
No. reflections (total/free) 12,772/1,277 10,276/521
Rwork/Rfree 0.236/0.285 0.198/0.240
Number of atoms
Protein 1,733 1,589
Ligand/ion 1
Water 13 89
B-factors
Protein 91.6 41.8
Ligand/ion 32.0
Water 69.3 37.8
All atoms 91.5 41.6
Wilson B 74.7 31.9
r.m.s. deviations
Bond lengths (Å) 0.002 0.002
Bond angles (°) 0.39 0.45
Ramachandran
distributionc (%)
Favored 96.6 97.5
Allowed 3.4 2.5
Outliers 0 0
Protein Data Bank code 5WAQ 5WAM
a Values in parentheses are for the highest-resolution shell.
b CC1⁄2: Pearson’s correlation coefficient (CC) between intensity estimates from
half data sets. Primary indicator for use for selecting high resolution cutoff for
data processing.
c Calculated using MolProbity.
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Supplementary Table S1. Oligonucleotides used in this study.  
 
Oligonucleotide Sequence1 (5’-3’) 
BamD-Up-F GACTGATAGAATTCGCAAGCTCGAGCGGAAC 
BamD-Up-R ATCGATGGTACCGTCTTGCGAGGCCAGTTTG 
BamD-Down-F GGATTTACGGATCCTGGTCCGACCGCGAC 
BamD-Down-R ACTCGGTCAAGCTTGGCGTAAAGGCTCAACGTTTG 
BamD-Ver-F GACGTGGGTTACGGCA 
BamD-Ver-R CGTGCCGAGTTTGAATGC 
rSurA-F GATCCCATGGCACCGCAAAAGGCAAAAAC 
rSurA-R GACTAAGCTTGCCTTAGCGGATGTCGAC 
rBamE-F  GAATTCCCATGGTCGAACGCGTCTCGCTGT 
rBamE-R GGATCCAAGCTTTTGTTTGTCTGCGTTTTGTTTCGC 
BamE-Up-F  AGGCCTGAGCTCGGCAGTTCTCCAAAAACACAGA 
BamE-Up-R CCGCGGTACCCACGGGAGAACCTTTCTGTG 
BamE-Down-F CGATCGGGATCCGCGAAACAAAACGCAGACAA 
BamE-Down-R GTTAACAAGCTTGAAGAGGGCGGTGTGGT 
BamE-Ver-F AAAGCATAGGCAGGATCGGG 
BamE-Ver-R CCTGCATATCGTACAAACCCG 
cBamE-F GATTTGCACAGAAAGGTTCTCC 
cBamE-R AAGCTTGGCCGGCCTCCTTATTGTTTGTCTGCGTTT 
1 Sequences recognized by restriction enzymes are underlined. Other primers not listed available upon 
request. 
 
 
 
 
Supplemental Figure S1. Sequence alignments of BamD and BamE for N. gonorrhoeae, N. 
meningitidis, and E. coli. The left panel shows the sequence alignment of BamD orthologs, while the panel 
on the right shows the sequence alignment for BamE orthologs.  
Supplemental Figure S2. Analysis of single nucleotide polymorphisms of BamE and BamD in 
Neisseria. Analysis of BamE (locus NEIP0196) and BamD (locus NEIP0653) was analyzed by comparing 
DNA sequences between 42,412 Neisseriae isolates deposited to the PubMLST 
(https://pubmlst.org/neisseria/), as of April 18, 2017, and demonstrated presence of 179 alleles with 89 
single nucleotide polymorphisms (SNPs) for BamE and 269 alleles with 186 SNPs for BamD.   
 
 
Supplemental Figure S3. Changes in the protein profiles of cell envelopes and membrane vesicles in 
the absence of BamEGC. Cell envelope (CE) and membrane vesicles (MV) proteins isolated from wt and 
∆bamE strains grown to mid-logarithmic phase of growth were normalized by total protein concentration, 
separated by SDS-PAGE, transferred onto nitrocellulose membrane, and probed with indicated antibodies. 
Migration of a molecular mass marker (kDa) is indicated on the left. *Denotes TamA (8).  
